宫内灌注富血小板血浆用于宫腔粘连分离术后辅助治疗的研究进展

Research advances in intrauterine perfusion of platelet-rich plasma for adjuvant therapy after hysteroscopic adhesiolysis

  • 摘要: 中-重度宫腔粘连(intrauterine adhesion,IUA)对女性生殖健康有极大的不良影响,且粘连分离术后复发率高、妊娠率低、妊娠结局不理想,给临床工作带来了极大挑战。自体富血小板血浆(platelet-rich plasma,PRP)含有高浓度血小板,是生长因子、细胞因子等生物活性因子的丰富来源,可促进细胞增殖、迁移、再生、细胞外基质合成、血管生成和上皮化。尽管PRP在医学领域广泛应用数十年,但其应用于宫腔粘连治疗尚处于初步探索阶段,其确切作用机制仍不清楚。本文综述了PRP治疗宫腔粘连的研究进展,并重点探讨了PRP治疗宫腔粘连的可能机制,为治疗宫腔粘连提供可能的理论依据。

     

    Abstract: Moderate to severe intrauterine adhesion (IUA) have great adverse effects on female reproductive health. The high adhesion recurrence rate, low pregnancy rate and unsatisfactory pregnancy outcome after hysteroscopic adhesiolysis have brought great challenges in clinical practice. Autologous platelet-rich plasma (PRP) contains high concentration of platelets, which is a rich source of bioactive factors such as growth factors and cytokines. These factors can promote cell proliferation, migration, regeneration, extracellular matrix remodeling, angiogenesis and epithelialization. Although PRP has been widely used in medicine for decades, its application in the treatment of IUA is still in the preliminary explore stage, and its exact mechanism remains unclear. This article reviews the research progress of PRP in the treatment of IUA, and focuses on its possible mechanism, in order to provide theoretical evidences for improving the therapeutic effect of IUA.

     

/

返回文章
返回